The HSB Blog

Our Take: Non-alcoholic fatty liver disease (NAFLD) affects 25% of the world's population, posing significant healthcare challenges as it...

Our Take: While AI holds the potential to radically transform clinical protocols and care, potentially bringing such things as AI-driven...

Our Take: The first AI models for medical use were approved by the FDA in 1995.  While only 50 were approved over the first 18 years, an...

Overview: “Digital Mental Health (DMH), involves providing mental health support through messages, videos, programs, applications, games,...

Our Take: Mental health needs in the U.S. have increased substantially driven in part by the isolation, stress and anxiety of the COVID...

The Driver: Xaira Therapeutics recently raised $1 billion to apply AI to the discovery and development of new drugs. As the company noted...